RedHill Biopharma (RDHL) EBT Margin Growth (3y) (2015 - 2023)
RedHill Biopharma (RDHL) EBT Margin Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 323,784.00 |
| Mar 31, 2023 | -177,751.00 |
| Dec 31, 2022 | -128,768.00 |
| Sep 30, 2022 | -85,189.00 |
| Jun 30, 2022 | -86,770.00 |
| Mar 31, 2022 | -39,543.00 |
| Dec 31, 2021 | -155,687.00 |
| Sep 30, 2021 | -36,356.00 |
| Jun 30, 2021 | -24,421.00 |
| Mar 31, 2021 | -34,592.00 |
| Dec 31, 2020 | -86,640.00 |
| Sep 30, 2020 | -76,627.00 |
| Jun 30, 2020 | -328,118.00 |
| Mar 31, 2020 | 23.37 Mn |
| Dec 31, 2019 | -890,253.00 |
| Dec 31, 2018 | -904,456.00 |
| Jun 30, 2018 | -51.81 Mn |
| Dec 31, 2017 | -39.73 Mn |
| Sep 30, 2017 | 73,286.00 |
| Jun 30, 2017 | 332,392.00 |